Current role
Holly Kordasiewicz, Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Holly Kordasiewicz, Ph.D.
Ionis Pharmaceuticals Inc reported in an 8-K filed June 12, 2025 that Holly Kordasiewicz, Ph.D. was appointed executive vice president and chief development officer, effective January 1, 2026.
“On June 12, 2025, the Company issued a press release announcing that Holly Kordasiewicz, Ph.D., currently senior vice president, neurology, will succeed Dr. Richard Geary Ph.D. in the role of executive vice president and chief development officer beginning in January 2026.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Ionis Pharmaceuticals Inc (IONS)
SEC 8-K
Current2026-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ionis Pharmaceuticals Inc
Other people whose current roles at this company are on record from its filings.
- Brett Monia CEO
- Elizabeth Hougen CFO
- Patrick R. O’Neil General Counsel
- Allene M. Diaz Board Member
- Ludwig N. Hantson Board Member
- Mariana Baroldi Board Member
- Michael Yang Board Member
- Peter N. Reikes Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.